24/7 Market News Snapshot 13 January, 2025 – Salarius Pharmaceuticals, Inc. Common Stock (NASDAQ:SLRX)

January 13, 2025

DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:SLRX) are discussed in this article.
Salarius Pharmaceuticals, Inc. (SLRX) has recently announced a significant merger with Decoy Therapeutics, Inc., culminating in the establishment of a new entity named Decoy Therapeutics. This strategic alignment aims to harness the innovative strengths of both companies to further develop pioneering therapeutic solutions, particularly through Decoy’s advanced IMP3ACT™ platform. This cutting-edge technology integrates machine learning and artificial intelligence to expedite the design and manufacturing of novel peptide conjugate therapeutics, addressing urgent health needs in respiratory viruses and cancer care.

The merger comes at a time when Salarius has garnered notable investor interest, demonstrating a dramatic rise in its share price, reflecting an impressive increase of 91.76% from the previous close. This bullish trend, coupled with a trading volume of 3.22 million shares, signals robust market activity and potential breakout opportunities for investors seeking to capitalize on the company’s upward trajectory.

Leadership for the newly formed Decoy Therapeutics will include Decoy’s co-founders, Frederick “Rick” Pierce and Barbara Hibner, along with key executives from both organizations. Their extensive expertise in biotech management and drug development is expected to be pivotal in navigating the complex pharmaceutical landscape.

Significantly, this merger is bolstered by substantial non-dilutive funding of approximately $7 million, sourced from federal entities, major corporations, and philanthropic contributions. With ambitious plans for the upcoming year, including advancing Decoy’s lead antiviral candidate and integrating Salarius’ existing pipeline, the new entity is set to achieve crucial clinical milestones, aiming to enhance shareholder value while transforming therapeutic approaches in critical medical domains.

Related news for (SLRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.